title: Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus.
authors.forename: Siavash
authors.initials: S
authors.lastname: Toosi
authors.forename: Nancy
authors.initials: N
authors.lastname: Habib
authors.forename: Genevieve
authors.initials: G
authors.lastname: Torres
authors.forename: Sandra R
authors.initials: SR
authors.lastname: Reynolds
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Bystryn
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000097:blood; D000368:Aged; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D051034:Inhibitor of Apoptosis Proteins / Q000097:blood*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood; D010392:Pemphigus / Q000097:blood* / Q000188:drug therapy*; D012720:Severity of Illness Index; D000077022:Survivin; D016896:Treatment Outcome; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000097:blood
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C107489:BIRC5 protein, human; C419866:BIRC7 protein, human; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D051034:Inhibitor of Apoptosis Proteins; D009363:Neoplasm Proteins; D000077022:Survivin; D051636:X-Linked Inhibitor of Apoptosis Protein